Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 252, pseudogene (RN7SL252P)

Target
RN7SL252P
Molecular classification
Other, Pseudogene, Non-coding RNA remnant
01

Overview

RN7SL252P (RNA, 7SL, cytoplasmic 252, pseudogene) is a pseudogene of the 7SL RNA component that normally forms part of the signal recognition particle (SRP), but as a pseudogene, it does not encode a functional protein or ncRNA, and is not known to play a canonical biological role[6][2][3]. Pseudogenes may nonetheless exhibit transcriptional activity and can impact gene regulation indirectly. RN7SL252P is a human pseudogene located on chromosome 7 that is part of the family of RN7SL pseudogenes derived from the 7SL RNA gene[6]. The parental gene, RN7SL1, codes for the 7SL RNA, which is the structural RNA essential for the signal recognition particle (SRP). SRP plays a crucial role in directing proteins to the endoplasmic reticulum membrane during translation[3][5][1]. However, as a pseudogene, RN7SL252P does not produce functional RNA or protein and has no established function or clinical relevance. In general, pseudogenes may have regulatory roles—such as acting as “decoys” for miRNAs or as sources of long non-coding RNAs—but there is no direct evidence of any biological, disease, or therapeutic role for this specific pseudogene[2][4]. If structured information requires valid molecular targets, RN7SL252P should be flagged as incorrect for that context—it is not a standard molecular target; instead, it is a non-functional genomic element[6][2][4].

Other names
RN7SL252PRNA, 7SL, cytoplasmic 252, pseudogene
02

Mechanism of action

None (not a drug target)

03

Biological functions

Possible indirect regulation of gene expression through long non-coding RNA-like effects or acting as a miRNA decoy (general functions of pseudogenes), but no specific functional evidence for RN7SL252P itself
04

Disease associations

No known direct role; some pseudogenes of RN7SL have altered expression in disease contexts but for RN7SL252P specifically there is no reported disease association
05

Safety considerations

None (no safety or therapeutic concerns, as it is not a therapeutic target)
06

Interacting drugs

None (no known drugs interact with this pseudogene)
07

Biomarkers

None (not used as a biomarker)

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 252, pseudogene (RN7SL252P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 252, pseudogene (RN7SL252P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call